These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 22309912)

  • 1. Design, synthesis and biological evaluation of 6-substituted aminocarbonyl benzimidazole derivatives as nonpeptidic angiotensin II AT1 receptor antagonists.
    Wang JL; Zhang J; Zhou ZM; Li ZH; Xue WZ; Xu D; Hao LP; Han XF; Fei F; Liu T; Liang AH
    Eur J Med Chem; 2012 Mar; 49():183-90. PubMed ID: 22309912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and biological activity of 6-substituted carbamoyl benzimidazoles as new nonpeptidic angiotensin II AT₁ receptor antagonists.
    Zhang J; Wang JL; Zhou ZM; Li ZH; Xue WZ; Xu D; Hao LP; Han XF; Fei F; Liu T; Liang AH
    Bioorg Med Chem; 2012 Jul; 20(14):4208-16. PubMed ID: 22727371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonpeptidic angiotensin II AT₁ receptor antagonists derived from 6-substituted aminocarbonyl and acylamino benzimidazoles.
    Zhang J; Wang JL; Yu WF; Zhou ZM; Tao WC; Wang YC; Xue WZ; Xu D; Hao LP; Han XF; Fei F; Liu T; Liang AH
    Eur J Med Chem; 2013 Nov; 69():44-54. PubMed ID: 24007859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II--AT1 receptor antagonists: design, synthesis and evaluation of substituted carboxamido benzimidazole derivatives.
    Shah DI; Sharma M; Bansal Y; Bansal G; Singh M
    Eur J Med Chem; 2008 Sep; 43(9):1808-12. PubMed ID: 18158200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and biological evaluation of AT
    Wu Z; Anh NTP; Yan YJ; Xia MB; Wang YH; Qiu Y; Chen ZL
    Eur J Med Chem; 2019 Nov; 181():111553. PubMed ID: 31369932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of novel, potent and low-toxicity angiotensin II receptor type 1 (AT1) blockers: Design, synthesis and biological evaluation of 6-substituted aminocarbonyl benzimidazoles with a chiral center.
    Han XF; He X; Wang M; Xu D; Hao LP; Liang AH; Zhang J; Zhou ZM
    Eur J Med Chem; 2015 Oct; 103():473-87. PubMed ID: 26397395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and docking studies of novel benzimidazoles for the treatment of metabolic syndrome.
    Mizuno CS; Chittiboyina AG; Shah FH; Patny A; Kurtz TW; Pershadsingh HA; Speth RC; Karamyan VT; Carvalho PB; Avery MA
    J Med Chem; 2010 Feb; 53(3):1076-85. PubMed ID: 20073471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, pharmacological evaluation and in silico ADMET prediction of novel substituted benzimidazole derivatives as angiotensin II-AT1 receptor antagonists based on predictive 3D QSAR models.
    Vyas VK; Gupta N; Ghate M; Patel S
    SAR QSAR Environ Res; 2014; 25(2):117-46. PubMed ID: 24598006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological activity of 2-alkylbenzimidazoles bearing a N-phenylpyrrole moiety as novel angiotensin II AT1 receptor antagonists.
    Xu JY; Zeng Y; Ran Q; Wei Z; Bi Y; He QH; Wang QJ; Hu S; Zhang J; Tang MY; Hua WY; Wu XM
    Bioorg Med Chem Lett; 2007 May; 17(10):2921-6. PubMed ID: 17412584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The discovery of new potent non-peptide Angiotensin II AT1 receptor blockers: a concise synthesis, molecular docking studies and biological evaluation of N-substituted 5-butylimidazole derivatives.
    Agelis G; Resvani A; Durdagi S; Spyridaki K; Tůmová T; Slaninová J; Giannopoulos P; Vlahakos D; Liapakis G; Mavromoustakos T; Matsoukas J
    Eur J Med Chem; 2012 Sep; 55():358-74. PubMed ID: 22889560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of new tetrazolyl- and carboxy-biphenylylmethyl-quinazolin-4-one derivatives as angiotensin II AT1 receptor antagonists.
    Ismail MA; Barker S; Abou el-Ella DA; Abouzid KA; Toubar RA; Todd MH
    J Med Chem; 2006 Mar; 49(5):1526-35. PubMed ID: 16509571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of novel potent angiotensin II receptor antagonists with anti-hypertension effect.
    Nie YY; Da YJ; Zheng H; Yang XX; Jia L; Wen CH; Liang LS; Tian J; Chen ZL
    Bioorg Med Chem; 2012 Apr; 20(8):2747-61. PubMed ID: 22410249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computer--based drug design, synthesis and biological evaluation of new pyrimidinone derivatives linked to arylpiperazine and 2'-carbethoxy-biphenylylmethyl moeities as alpha1-adrenoceptor antagonists and angiotensin II AT1 receptor antagonists.
    Ismail MA; Abou El Ella DA; Abouzid KA; Al-Ansary GH
    Pharmazie; 2010 Nov; 65(11):794-800. PubMed ID: 21155384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and evaluation of imidazo[4,5-c]pyridin-4-one derivatives with dual activity at angiotensin II type 1 receptor and peroxisome proliferator-activated receptor-γ.
    Casimiro-Garcia A; Heemstra RJ; Bigge CF; Chen J; Ciske FA; Davis JA; Ellis T; Esmaeil N; Flynn D; Han S; Jalaie M; Ohren JF; Powell NA
    Bioorg Med Chem Lett; 2013 Feb; 23(3):767-72. PubMed ID: 23265881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological activities of novel nonpeptide angiotensin II receptor antagonists based on benzimidazole derivatives bearing a heterocyclic ring.
    Guo XZ; Shi L; Wang R; Liu XX; Li BG; Lu XX
    Bioorg Med Chem; 2008 Dec; 16(24):10301-10. PubMed ID: 18976926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and evaluation of novelly substituted benzimidazole compounds as angiotensin II receptor antagonists.
    Bali A; Bansal Y; Sugumaran M; Saggu JS; Balakumar P; Kaur G; Bansal G; Sharma A; Singh M
    Bioorg Med Chem Lett; 2005 Sep; 15(17):3962-5. PubMed ID: 16039125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and biological evaluation of new 5-nitro benzimidazole derivatives as AT1 antagonists with anti-hypertension activities.
    Zhu W; Da Y; Wu D; Zheng H; Zhu L; Wang L; Yan Y; Chen Z
    Bioorg Med Chem; 2014 Apr; 22(7):2294-302. PubMed ID: 24613628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro antagonistic properties of a new angiotensin type 1 receptor blocker, azilsartan, in receptor binding and function studies.
    Ojima M; Igata H; Tanaka M; Sakamoto H; Kuroita T; Kohara Y; Kubo K; Fuse H; Imura Y; Kusumoto K; Nagaya H
    J Pharmacol Exp Ther; 2011 Mar; 336(3):801-8. PubMed ID: 21123673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, biosimulation and pharmacological evaluation of benzimidazole derivatives with antihypertensive multitarget effect.
    Gutiérrez-Hernández A; Estrada-Soto S; Martínez-Conde C; Gaona-Tovar E; Medina-Franco JL; Hernández-Núñez E; Hidalgo-Figueroa S; Castro-Moreno P; Ibarra-Barajas M; Navarrete-Vazquez G
    Bioorg Med Chem Lett; 2024 Sep; 110():129879. PubMed ID: 38977106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and evaluation of novel potent angiotensin II receptor 1 antagonists.
    Bao X; Zhu W; Yuan W; Zhu X; Yan Y; Tang H; Chen Z
    Eur J Med Chem; 2016 Nov; 123():115-127. PubMed ID: 27474928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.